nodes	percent_of_prediction	percent_of_DWPC	metapath
Mivacurium—BCHE—Triamcinolone—psoriasis	0.0352	1	CbGbCtD
Mivacurium—Wheezing—Beclomethasone—psoriasis	0.0267	0.0277	CcSEcCtD
Mivacurium—Hypoxemia—Methotrexate—psoriasis	0.025	0.0259	CcSEcCtD
Mivacurium—Erythema—Calcipotriol—psoriasis	0.0211	0.0219	CcSEcCtD
Mivacurium—Bronchospasm—Beclomethasone—psoriasis	0.017	0.0176	CcSEcCtD
Mivacurium—Wheezing—Fluocinolone Acetonide—psoriasis	0.0165	0.0171	CcSEcCtD
Mivacurium—Erythema—Tazarotene—psoriasis	0.0156	0.0162	CcSEcCtD
Mivacurium—Erythema—Clobetasol propionate—psoriasis	0.0132	0.0137	CcSEcCtD
Mivacurium—Immune system disorder—Fluocinonide—psoriasis	0.0124	0.0128	CcSEcCtD
Mivacurium—Erythema—Fluocinonide—psoriasis	0.0119	0.0124	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Clobetasol propionate—psoriasis	0.0112	0.0116	CcSEcCtD
Mivacurium—Wheezing—Mycophenolic acid—psoriasis	0.0109	0.0113	CcSEcCtD
Mivacurium—Rash—Calcipotriol—psoriasis	0.0109	0.0113	CcSEcCtD
Mivacurium—Dermatitis—Calcipotriol—psoriasis	0.0109	0.0113	CcSEcCtD
Mivacurium—Skin disorder—Clobetasol propionate—psoriasis	0.0105	0.0109	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Fluocinonide—psoriasis	0.0101	0.0104	CcSEcCtD
Mivacurium—Anaphylactic shock—Beclomethasone—psoriasis	0.00982	0.0102	CcSEcCtD
Mivacurium—Arrhythmia—Methoxsalen—psoriasis	0.00966	0.01	CcSEcCtD
Mivacurium—Phlebitis—Mycophenolic acid—psoriasis	0.00946	0.0098	CcSEcCtD
Mivacurium—Skin disorder—Fluocinonide—psoriasis	0.00945	0.0098	CcSEcCtD
Mivacurium—Erythema—Methoxsalen—psoriasis	0.00941	0.00975	CcSEcCtD
Mivacurium—Muscle spasms—Methoxsalen—psoriasis	0.00905	0.00938	CcSEcCtD
Mivacurium—Injection site reaction—Mycophenolate mofetil—psoriasis	0.00881	0.00913	CcSEcCtD
Mivacurium—Arrhythmia—Calcitriol—psoriasis	0.00861	0.00892	CcSEcCtD
Mivacurium—Erythema—Calcitriol—psoriasis	0.00839	0.00869	CcSEcCtD
Mivacurium—Rash—Tazarotene—psoriasis	0.00802	0.00832	CcSEcCtD
Mivacurium—Dermatitis—Tazarotene—psoriasis	0.00802	0.00831	CcSEcCtD
Mivacurium—Flushing—Acitretin—psoriasis	0.00795	0.00825	CcSEcCtD
Mivacurium—Hypoxia—Methotrexate—psoriasis	0.0079	0.00819	CcSEcCtD
Mivacurium—Urticaria—Beclomethasone—psoriasis	0.0078	0.00809	CcSEcCtD
Mivacurium—Angiopathy—Acitretin—psoriasis	0.00778	0.00806	CcSEcCtD
Mivacurium—Immune system disorder—Acitretin—psoriasis	0.00774	0.00802	CcSEcCtD
Mivacurium—Mediastinal disorder—Fluocinolone Acetonide—psoriasis	0.0077	0.00798	CcSEcCtD
Mivacurium—Phlebitis—Mycophenolate mofetil—psoriasis	0.00746	0.00774	CcSEcCtD
Mivacurium—Erythema—Acitretin—psoriasis	0.00746	0.00773	CcSEcCtD
Mivacurium—Skin disorder—Methoxsalen—psoriasis	0.00746	0.00773	CcSEcCtD
Mivacurium—Erythema—Fluocinolone Acetonide—psoriasis	0.00744	0.00771	CcSEcCtD
Mivacurium—Wheezing—Triamcinolone—psoriasis	0.00738	0.00765	CcSEcCtD
Mivacurium—Hypotension—Methoxsalen—psoriasis	0.00718	0.00744	CcSEcCtD
Mivacurium—Muscle spasms—Acitretin—psoriasis	0.00717	0.00744	CcSEcCtD
Mivacurium—Anaphylactic shock—Calcitriol—psoriasis	0.00685	0.00709	CcSEcCtD
Mivacurium—Anaphylactoid reaction—Cyclosporine—psoriasis	0.00681	0.00706	CcSEcCtD
Mivacurium—Rash—Clobetasol propionate—psoriasis	0.0068	0.00705	CcSEcCtD
Mivacurium—Dermatitis—Clobetasol propionate—psoriasis	0.0068	0.00704	CcSEcCtD
Mivacurium—Skin disorder—Calcitriol—psoriasis	0.00665	0.00689	CcSEcCtD
Mivacurium—Dizziness—Beclomethasone—psoriasis	0.00649	0.00673	CcSEcCtD
Mivacurium—Dizziness—Fluocinonide—psoriasis	0.00643	0.00667	CcSEcCtD
Mivacurium—Anaphylactoid reaction—Prednisolone—psoriasis	0.0062	0.00642	CcSEcCtD
Mivacurium—Rash—Beclomethasone—psoriasis	0.00619	0.00642	CcSEcCtD
Mivacurium—Dermatitis—Beclomethasone—psoriasis	0.00619	0.00641	CcSEcCtD
Mivacurium—Rash—Fluocinonide—psoriasis	0.00614	0.00636	CcSEcCtD
Mivacurium—Dermatitis—Fluocinonide—psoriasis	0.00613	0.00635	CcSEcCtD
Mivacurium—Angiopathy—Hydroxyurea—psoriasis	0.00611	0.00633	CcSEcCtD
Mivacurium—Urticaria—Methoxsalen—psoriasis	0.0061	0.00632	CcSEcCtD
Mivacurium—Anaphylactoid reaction—Hydrocortisone—psoriasis	0.00605	0.00627	CcSEcCtD
Mivacurium—Skin disorder—Acitretin—psoriasis	0.00591	0.00613	CcSEcCtD
Mivacurium—Erythema—Hydroxyurea—psoriasis	0.00586	0.00607	CcSEcCtD
Mivacurium—Bradycardia—Mycophenolic acid—psoriasis	0.00574	0.00595	CcSEcCtD
Mivacurium—Anaphylactoid reaction—Triamcinolone—psoriasis	0.0057	0.00591	CcSEcCtD
Mivacurium—Bronchospasm—Cyclosporine—psoriasis	0.0056	0.00581	CcSEcCtD
Mivacurium—Urticaria—Calcitriol—psoriasis	0.00544	0.00564	CcSEcCtD
Mivacurium—Cardiac disorder—Mycophenolic acid—psoriasis	0.00523	0.00542	CcSEcCtD
Mivacurium—Anaphylactoid reaction—Betamethasone—psoriasis	0.00517	0.00536	CcSEcCtD
Mivacurium—Anaphylactoid reaction—Dexamethasone—psoriasis	0.00517	0.00536	CcSEcCtD
Mivacurium—Angiopathy—Mycophenolic acid—psoriasis	0.00511	0.0053	CcSEcCtD
Mivacurium—Mediastinal disorder—Mycophenolic acid—psoriasis	0.00508	0.00526	CcSEcCtD
Mivacurium—Dizziness—Methoxsalen—psoriasis	0.00508	0.00526	CcSEcCtD
Mivacurium—Arrhythmia—Mycophenolic acid—psoriasis	0.00503	0.00522	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—psoriasis	0.00495	0.00513	CcSEcCtD
Mivacurium—Rash—Methoxsalen—psoriasis	0.00484	0.00502	CcSEcCtD
Mivacurium—Dermatitis—Methoxsalen—psoriasis	0.00484	0.00501	CcSEcCtD
Mivacurium—Urticaria—Acitretin—psoriasis	0.00484	0.00501	CcSEcCtD
Mivacurium—Muscle spasms—Mycophenolic acid—psoriasis	0.00472	0.00489	CcSEcCtD
Mivacurium—Skin disorder—Hydroxyurea—psoriasis	0.00464	0.00481	CcSEcCtD
Mivacurium—Bradycardia—Mycophenolate mofetil—psoriasis	0.00453	0.00469	CcSEcCtD
Mivacurium—Rash—Calcitriol—psoriasis	0.00432	0.00447	CcSEcCtD
Mivacurium—Dermatitis—Calcitriol—psoriasis	0.00431	0.00447	CcSEcCtD
Mivacurium—Flushing—Cyclosporine—psoriasis	0.00423	0.00439	CcSEcCtD
Mivacurium—Bradycardia—Prednisolone—psoriasis	0.00422	0.00438	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—psoriasis	0.00415	0.0043	CcSEcCtD
Mivacurium—Angiopathy—Cyclosporine—psoriasis	0.00414	0.00429	CcSEcCtD
Mivacurium—Cardiac disorder—Mycophenolate mofetil—psoriasis	0.00413	0.00428	CcSEcCtD
Mivacurium—Bradycardia—Hydrocortisone—psoriasis	0.00413	0.00428	CcSEcCtD
Mivacurium—Mediastinal disorder—Cyclosporine—psoriasis	0.00411	0.00426	CcSEcCtD
Mivacurium—Arrhythmia—Cyclosporine—psoriasis	0.00407	0.00422	CcSEcCtD
Mivacurium—Angiopathy—Mycophenolate mofetil—psoriasis	0.00404	0.00418	CcSEcCtD
Mivacurium—Dizziness—Acitretin—psoriasis	0.00403	0.00417	CcSEcCtD
Mivacurium—Dizziness—Fluocinolone Acetonide—psoriasis	0.00402	0.00416	CcSEcCtD
Mivacurium—Mediastinal disorder—Mycophenolate mofetil—psoriasis	0.00401	0.00416	CcSEcCtD
Mivacurium—Arrhythmia—Mycophenolate mofetil—psoriasis	0.00397	0.00412	CcSEcCtD
Mivacurium—Tachycardia—Mycophenolic acid—psoriasis	0.00391	0.00405	CcSEcCtD
Mivacurium—Skin disorder—Mycophenolic acid—psoriasis	0.00389	0.00403	CcSEcCtD
Mivacurium—Bradycardia—Triamcinolone—psoriasis	0.00388	0.00403	CcSEcCtD
Mivacurium—Rash—Acitretin—psoriasis	0.00384	0.00398	CcSEcCtD
Mivacurium—Dermatitis—Acitretin—psoriasis	0.00384	0.00398	CcSEcCtD
Mivacurium—Rash—Fluocinolone Acetonide—psoriasis	0.00383	0.00397	CcSEcCtD
Mivacurium—Dermatitis—Fluocinolone Acetonide—psoriasis	0.00383	0.00396	CcSEcCtD
Mivacurium—Muscle spasms—Cyclosporine—psoriasis	0.00382	0.00396	CcSEcCtD
Mivacurium—Anaphylactoid reaction—Methotrexate—psoriasis	0.00376	0.0039	CcSEcCtD
Mivacurium—Hypotension—Mycophenolic acid—psoriasis	0.00374	0.00388	CcSEcCtD
Mivacurium—Muscle spasms—Mycophenolate mofetil—psoriasis	0.00372	0.00386	CcSEcCtD
Mivacurium—Arrhythmia—Prednisolone—psoriasis	0.00371	0.00384	CcSEcCtD
Mivacurium—Immune system disorder—Hydrocortisone—psoriasis	0.00366	0.00379	CcSEcCtD
Mivacurium—Arrhythmia—Hydrocortisone—psoriasis	0.00362	0.00375	CcSEcCtD
Mivacurium—Erythema—Prednisolone—psoriasis	0.00361	0.00374	CcSEcCtD
Mivacurium—Erythema—Hydrocortisone—psoriasis	0.00353	0.00366	CcSEcCtD
Mivacurium—Bradycardia—Betamethasone—psoriasis	0.00352	0.00365	CcSEcCtD
Mivacurium—Bradycardia—Dexamethasone—psoriasis	0.00352	0.00365	CcSEcCtD
Mivacurium—Arrhythmia—Triamcinolone—psoriasis	0.00341	0.00353	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—psoriasis	0.00336	0.00348	CcSEcCtD
Mivacurium—Erythema—Triamcinolone—psoriasis	0.00332	0.00344	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—psoriasis	0.00327	0.00339	CcSEcCtD
Mivacurium—Anaphylactic shock—Cyclosporine—psoriasis	0.00324	0.00336	CcSEcCtD
Mivacurium—Dizziness—Hydroxyurea—psoriasis	0.00316	0.00328	CcSEcCtD
Mivacurium—Anaphylactic shock—Mycophenolate mofetil—psoriasis	0.00316	0.00328	CcSEcCtD
Mivacurium—Skin disorder—Cyclosporine—psoriasis	0.00315	0.00326	CcSEcCtD
Mivacurium—Angiopathy—Betamethasone—psoriasis	0.00314	0.00326	CcSEcCtD
Mivacurium—Angiopathy—Dexamethasone—psoriasis	0.00314	0.00326	CcSEcCtD
Mivacurium—Arrhythmia—Betamethasone—psoriasis	0.00309	0.00321	CcSEcCtD
Mivacurium—Arrhythmia—Dexamethasone—psoriasis	0.00309	0.00321	CcSEcCtD
Mivacurium—Tachycardia—Mycophenolate mofetil—psoriasis	0.00308	0.0032	CcSEcCtD
Mivacurium—Skin disorder—Mycophenolate mofetil—psoriasis	0.00307	0.00318	CcSEcCtD
Mivacurium—Bradycardia—Prednisone—psoriasis	0.00307	0.00318	CcSEcCtD
Mivacurium—Rash—Hydroxyurea—psoriasis	0.00301	0.00312	CcSEcCtD
Mivacurium—Erythema—Dexamethasone—psoriasis	0.00301	0.00312	CcSEcCtD
Mivacurium—Erythema—Betamethasone—psoriasis	0.00301	0.00312	CcSEcCtD
Mivacurium—Dermatitis—Hydroxyurea—psoriasis	0.00301	0.00312	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—psoriasis	0.00298	0.00309	CcSEcCtD
Mivacurium—Hypotension—Mycophenolate mofetil—psoriasis	0.00295	0.00306	CcSEcCtD
Mivacurium—Anaphylactic shock—Prednisolone—psoriasis	0.00295	0.00306	CcSEcCtD
Mivacurium—Anaphylactic shock—Hydrocortisone—psoriasis	0.00288	0.00298	CcSEcCtD
Mivacurium—Tachycardia—Prednisolone—psoriasis	0.00288	0.00298	CcSEcCtD
Mivacurium—Tachycardia—Hydrocortisone—psoriasis	0.00281	0.00291	CcSEcCtD
Mivacurium—Flushing—Prednisone—psoriasis	0.0028	0.0029	CcSEcCtD
Mivacurium—Skin disorder—Hydrocortisone—psoriasis	0.0028	0.0029	CcSEcCtD
Mivacurium—Angiopathy—Prednisone—psoriasis	0.00274	0.00284	CcSEcCtD
Mivacurium—Immune system disorder—Prednisone—psoriasis	0.00272	0.00282	CcSEcCtD
Mivacurium—Anaphylactic shock—Triamcinolone—psoriasis	0.00271	0.00281	CcSEcCtD
Mivacurium—Arrhythmia—Prednisone—psoriasis	0.00269	0.00279	CcSEcCtD
Mivacurium—Hypotension—Hydrocortisone—psoriasis	0.00269	0.00279	CcSEcCtD
Mivacurium—Dizziness—Mycophenolic acid—psoriasis	0.00265	0.00274	CcSEcCtD
Mivacurium—Tachycardia—Triamcinolone—psoriasis	0.00265	0.00274	CcSEcCtD
Mivacurium—Erythema—Prednisone—psoriasis	0.00262	0.00272	CcSEcCtD
Mivacurium—Urticaria—Cyclosporine—psoriasis	0.00257	0.00267	CcSEcCtD
Mivacurium—Rash—Mycophenolic acid—psoriasis	0.00252	0.00262	CcSEcCtD
Mivacurium—Dermatitis—Mycophenolic acid—psoriasis	0.00252	0.00261	CcSEcCtD
Mivacurium—Urticaria—Mycophenolate mofetil—psoriasis	0.00251	0.0026	CcSEcCtD
Mivacurium—Anaphylactic shock—Dexamethasone—psoriasis	0.00246	0.00255	CcSEcCtD
Mivacurium—Anaphylactic shock—Betamethasone—psoriasis	0.00246	0.00255	CcSEcCtD
Mivacurium—Tachycardia—Betamethasone—psoriasis	0.0024	0.00249	CcSEcCtD
Mivacurium—Tachycardia—Dexamethasone—psoriasis	0.0024	0.00249	CcSEcCtD
Mivacurium—Urticaria—Prednisolone—psoriasis	0.00234	0.00243	CcSEcCtD
Mivacurium—Cardiac disorder—Methotrexate—psoriasis	0.00234	0.00242	CcSEcCtD
Mivacurium—Hypotension—Betamethasone—psoriasis	0.0023	0.00238	CcSEcCtD
Mivacurium—Hypotension—Dexamethasone—psoriasis	0.0023	0.00238	CcSEcCtD
Mivacurium—Urticaria—Hydrocortisone—psoriasis	0.00229	0.00237	CcSEcCtD
Mivacurium—Angiopathy—Methotrexate—psoriasis	0.00229	0.00237	CcSEcCtD
Mivacurium—Immune system disorder—Methotrexate—psoriasis	0.00228	0.00236	CcSEcCtD
Mivacurium—Mediastinal disorder—Methotrexate—psoriasis	0.00227	0.00235	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	0.00222	0.0023	CcSEcCtD
Mivacurium—Erythema—Methotrexate—psoriasis	0.00219	0.00227	CcSEcCtD
Mivacurium—Urticaria—Triamcinolone—psoriasis	0.00215	0.00223	CcSEcCtD
Mivacurium—Dizziness—Cyclosporine—psoriasis	0.00214	0.00222	CcSEcCtD
Mivacurium—Anaphylactic shock—Prednisone—psoriasis	0.00214	0.00222	CcSEcCtD
Mivacurium—Tachycardia—Prednisone—psoriasis	0.00209	0.00217	CcSEcCtD
Mivacurium—Dizziness—Mycophenolate mofetil—psoriasis	0.00209	0.00217	CcSEcCtD
Mivacurium—Skin disorder—Prednisone—psoriasis	0.00208	0.00216	CcSEcCtD
Mivacurium—Rash—Cyclosporine—psoriasis	0.00204	0.00212	CcSEcCtD
Mivacurium—Dermatitis—Cyclosporine—psoriasis	0.00204	0.00212	CcSEcCtD
Mivacurium—Rash—Mycophenolate mofetil—psoriasis	0.00199	0.00207	CcSEcCtD
Mivacurium—Dermatitis—Mycophenolate mofetil—psoriasis	0.00199	0.00206	CcSEcCtD
Mivacurium—Urticaria—Betamethasone—psoriasis	0.00195	0.00203	CcSEcCtD
Mivacurium—Urticaria—Dexamethasone—psoriasis	0.00195	0.00203	CcSEcCtD
Mivacurium—Dizziness—Prednisolone—psoriasis	0.00195	0.00202	CcSEcCtD
Mivacurium—Dizziness—Hydrocortisone—psoriasis	0.0019	0.00197	CcSEcCtD
Mivacurium—Rash—Prednisolone—psoriasis	0.00186	0.00193	CcSEcCtD
Mivacurium—Dermatitis—Prednisolone—psoriasis	0.00186	0.00192	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	0.00185	0.00192	CcSEcCtD
Mivacurium—Rash—Hydrocortisone—psoriasis	0.00182	0.00188	CcSEcCtD
Mivacurium—Dermatitis—Hydrocortisone—psoriasis	0.00181	0.00188	CcSEcCtD
Mivacurium—Dizziness—Triamcinolone—psoriasis	0.00179	0.00186	CcSEcCtD
Mivacurium—Anaphylactic shock—Methotrexate—psoriasis	0.00179	0.00186	CcSEcCtD
Mivacurium—Skin disorder—Methotrexate—psoriasis	0.00174	0.0018	CcSEcCtD
Mivacurium—Rash—Triamcinolone—psoriasis	0.00171	0.00177	CcSEcCtD
Mivacurium—Dermatitis—Triamcinolone—psoriasis	0.00171	0.00177	CcSEcCtD
Mivacurium—Urticaria—Prednisone—psoriasis	0.0017	0.00176	CcSEcCtD
Mivacurium—Hypotension—Methotrexate—psoriasis	0.00167	0.00173	CcSEcCtD
Mivacurium—Dizziness—Betamethasone—psoriasis	0.00163	0.00169	CcSEcCtD
Mivacurium—Dizziness—Dexamethasone—psoriasis	0.00163	0.00169	CcSEcCtD
Mivacurium—Rash—Dexamethasone—psoriasis	0.00155	0.00161	CcSEcCtD
Mivacurium—Rash—Betamethasone—psoriasis	0.00155	0.00161	CcSEcCtD
Mivacurium—Dermatitis—Betamethasone—psoriasis	0.00155	0.00161	CcSEcCtD
Mivacurium—Dermatitis—Dexamethasone—psoriasis	0.00155	0.00161	CcSEcCtD
Mivacurium—Urticaria—Methotrexate—psoriasis	0.00142	0.00147	CcSEcCtD
Mivacurium—Dizziness—Prednisone—psoriasis	0.00142	0.00147	CcSEcCtD
Mivacurium—Rash—Prednisone—psoriasis	0.00135	0.0014	CcSEcCtD
Mivacurium—Dermatitis—Prednisone—psoriasis	0.00135	0.0014	CcSEcCtD
Mivacurium—Dizziness—Methotrexate—psoriasis	0.00118	0.00123	CcSEcCtD
Mivacurium—Rash—Methotrexate—psoriasis	0.00113	0.00117	CcSEcCtD
Mivacurium—Dermatitis—Methotrexate—psoriasis	0.00113	0.00117	CcSEcCtD
